Skip to content

Mirum Pharmaceuticals

US · MIRM #2051 by market cap Listed 2019
96.13 +0.62 +0.65%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    RBC Capital Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $155
    Market Newswire · 2026/10/8
  • Rating change
    TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $145
    Market Newswire · 2026/10/21
  • H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $202
    Market Newswire · 2026/11/11
  • Rating change
    H.C. Wainwright Initiates Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Announces Target Price $195
    Market Newswire · 2026/10/22
  • Rating change
    Leerink Partners Initiates Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Announces Target Price $140
    Market Newswire · 2026/11/5
  • Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $194
    Market Newswire · 2026/11/11
  • Rating change
    Baird Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $130
    Market Newswire · 2026/9/30
  • Rating change
    Stifel Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $156
    Market Newswire · 2026/10/15
  • Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $194
    Market Newswire · 2026/11/11
  • Rating change
    H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $195
    Market Newswire · 2026/10/8
  • Rating change
    Stifel Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $156
    Market Newswire · 2026/10/15
  • Rating change
    Citizens JMP Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $167
    Market Newswire · 2026/11/4
  • Rating change
    Evercore Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $146
    Market Newswire · 2026/10/13
  • Rating change
    Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $184
    Market Newswire · 2026/10/13
  • Rating change
    Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $152
    Market Newswire · 2026/10/13
  • Rating change
    H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $200
    Market Newswire · 2026/10/27
  • Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $152
    Market Newswire · 2026/11/5
  • Rating change
    Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $160
    Market Newswire · 2026/9/30
  • J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating
    Market Newswire · 2026/11/10
  • Rating change
    Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $184
    Market Newswire · 2026/11/10
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM)
    TipRanks · 2026/9/10
  • Rating change
    Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $145
    Market Newswire · 2026/9/10
  • Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $152
    Market Newswire · 2026/10/13
  • Rating change
    A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $130 to $195
    Market Newswire · 2026/9/29
  • Rating change
    J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $118
    Market Newswire · 2026/8/11

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Mirum Pharmaceuticals discussion 0 comments

Add a comment